C
ORGO icon

Covestor’s Organogenesis Holdings ORGO Stock Holding History

Covestor’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Buy
156
+136
+680% +$332 ﹤0.01% 2746
2026
Q1 		$0 Hold
20
– – ﹤0.01% 2635
2025
Q4 		$0 Hold
20
– – ﹤0.01% 2609
2025
Q3 		$0 Hold
20
– – ﹤0.01% 2624
2025
Q2 		$0 Sell
20
-1
-5% -$4 ﹤0.01% 2597
2025
Q1 		$0 Hold
21
– – ﹤0.01% 2585
2024
Q4 		$0 Buy
21
+1
+5% +$3 ﹤0.01% 2592
2024
Q3 		$0 Sell
20
-1
-5% -$3 ﹤0.01% 2596
2024
Q2 		$0 Hold
21
– – ﹤0.01% 2607
2024
Q1 		$0 Sell
21
-2
-9% -$7 ﹤0.01% 2595
2023
Q4 		$0 Sell
23
-2
-8% -$6 ﹤0.01% 2547
2023
Q3 		$0 Sell
25
-26
-51% -$83 ﹤0.01% 2535
2023
Q2 		$0 Buy
51
+28
+122% +$83 ﹤0.01% 2494
2023
Q1 		$0 Hold
23
– – ﹤0.01% 2418
2022
Q4 		$0 Sell
23
-1
-4% -$3 ﹤0.01% 2445
2022
Q3 		$0 Sell
24
-132
-85% -$596 ﹤0.01% 2411
2022
Q2 		$1K Buy
156
+47
+43% +$289 ﹤0.01% 1775
2022
Q1 		$1K Buy
109
+28
+35% +$217 ﹤0.01% 1909
2021
Q4 		$1K Buy
+81
New +$860 ﹤0.01% 1871

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Covestor's ORGO Position: Q2 2026 in Review

Covestor increased its Organogenesis Holdings (ORGO) stake by 680% in Q2 2026, buying an estimated $332 and bringing the position to 156 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2746.

Covestor first reported a position in ORGO in Q4 2021 and has held it in 19 quarters since. The position peaked at $1K in Q2 2022. 135 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • Covestor held 156 shares of Organogenesis Holdings worth $0 as of Q2 2026.
  • Covestor bought 136 Organogenesis Holdings shares in Q2 2026, an estimated $332.
  • Organogenesis Holdings made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #2746 holding.
  • Covestor first reported a position in Organogenesis Holdings in Q4 2021 and has held it in 19 quarters since.
  • Covestor's Organogenesis Holdings position peaked at $1K in Q2 2022.
  • 135 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.